Originally published in eMerge Insights 2020 Annual Report
Carevive Systems is on a mission to bring the voice of the patient into routine care to improve outcomes.
Founded in 2013 and led by Founder and Vice Chairman Madelyn Trupkin Herzfeld, Carevive Systems is an oncology-focused health technology company focused on understanding and improving the oncology patient experience. Carevive, headquartered in North Miami, enables providers to deliver better quality
cancer care, and patients to be more engaged in their care, improving survival outcomes.
Leading oncology care providers are already using Carevive’ software embedded within their EHR workflows to generate personalized cancer patient care plans and to remotely monitor and manage patient symptoms at home. Use of Carevive in the clinic unlocks critical data in the real-world cancer patient experience to not only improve patient care today but improve access to novel therapies in the future.
Carevive is building 16 cancer-specific patient experience databases to enable providers to continuously improve patient care, receive better access to novel therapies of the future, and inform innovative and efficient clinical trial design. Its current customer base includes dozens of leading community and academic health systems across the U.S. who are now joining Carevive OPT-IN® (The Oncology Pragmatic Trial Investigator Network) to build one of the largest patient experience data repositories in the world, the company said. This data will provide the critical missing puzzle piece in today’s available real-world evidence.
Last year, the oncology-focused health technology company received $15 million in Series C funding from new investors Philips Health Technology Ventures and Debiopharm Innovation Fund, and existing investors Cerner Capital, HLM Venture Partners, and LRVHealth. In total, the company has raised $22.2 million, according to Crunchbase.
“We are grateful for the opportunity to work with passionate clinicians and researchers dedicated to advancing cancer care. Together, we are proving that Carevive technology improves cancer patient engagement and ultimately survival outcomes. The real-world Patient Experience Database we are building will enable oncologists to offer the best possible treatment choices for patients and will be invaluable in the development of breakthrough therapies that offer the promise of curing cancer in the future,” said Herzfeld, in making the funding announcement.
Before co-founding Carevive, Herzfeld founded and managed the Institute for Medical Education and Research in Miami. Before that, the Wharton grad worked in investment banking at Bear Stearns and Pinnacle Partners.